Syntrillo is a clinician-led company committed to rigorous scientific research.
We are enrolling stroke survivors and high-risk patients as part of two clinical studies to determine if our platform can improve outcomes, reduce readmission, and prevent stroke.
INITIAL OBSERVATIONS
While our research is ongoing, our observations from our initial cohort are:
60% reduction in extreme BP values
(SBP > 165 or < 90)
~80% optimal engagement with in-home devices
(at least 16 measurements per month)
75 blood pressure readings a month
per patient on average
More information can be found here:
*These findings are preliminary, not peer-reviewed, and subject to revision with further study.
INSTITUTIONAL REVIEW BOARDS
An institutional review board (IRB) is an independent committee established to help protect the rights of research participants. If you have any questions about your rights as a research participant, you are encouraged to contact your respective IRB.
OTHER HEALTH SYSTEMS
Study Subject Adviser, Advarra IRB
6100 Merriweather Dr., Suite 600
Columbia, MD 21044
877-992-4724
adviser@advarra.com
Please reference the following number when contacting the Study Subject Adviser: Pro00077460
VALLEY HEALTH
Winchester Medical Center
1840 Amherst Street
Winchester, VA 22601
540-536-4399
VHClinicalResearch@valleyhealthlink.com